> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Senators Seek Trump Admin. Actions to Cut Drug Costs
- URL: https://www.fdaweb.com/senators-seek-trump-admin-actions-to-cut-drug-costs/
- Published: 2017-05-15T12:00:00.000Z
- Updated: 2026-09-14T22:23:27.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5138687

Senators **Amy Klobuchar** (D-MN), **John McCain** (R-AZ), and **Chuck Grassley** (R-IA) have urged the Trump Administration to use existing executive authority to lower prescription drug costs, including a certification to allow importation of prescription drugs from Canada. The three have worked together on bipartisan legislation to allow personal importation of medications from Canada, and to deter pharmaceutical companies from blocking generic alternatives from entering the marketplace.

  
In a[ letter ](https://www.klobuchar.senate.gov/public/index.cfm/news-releases?ID=B11AC1F2-324F-4CF8-9EFF-E68D75B1EFB6&ref=fdaweb.com)to the administration, Klobuchar, McCain, and Grassley detail how it could use executive or administrative action to reduce the ever-increasing financial burden of prescription drugs for millions of Americans. “We urge you to seriously consider this existing statutory authority as well as explore other options for executive action,” they write. “We also ask that you please provide your recommendations as to what additional authority you would require to protect American consumers. Of course, we would welcome your support of our legislation to bring down the costs of prescription drugs as well.”